Search Results
Mar 13, 2026, 13:43 ET CRWV Deadline Today: CRWV Investors with Losses in Excess of $100K Have Opportunity to Lead CoreWeave, Inc. Securities Fraud Lawsuit
Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Mar 13, 2026, 10:30 ET Reply at NVIDIA GTC: Digital twins and physical AI driving the next stage of industrial value creation
[email protected]Tel. +39 0117711594Anusha [email protected]Tel. +1 (855) 864-9929
More news about: Reply
Mar 13, 2026, 09:59 ET Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
2026)Register and Webcast Link:https://research.citics.com/tel/info/1_2047925Participants are required to pre-register for the Mandarin conference call using the link above.Alternatively, participants
More news about: Insilico Medicine
Mar 13, 2026, 09:00 ET Milestone Systems Redefines the Open Platform for an AI-Native Era
Tel: +45 26 14 01 14 Tel: +45 41 76 02 72Tel: +45 50 84 29 55
More news about: Milestone Systems
Mar 13, 2026, 08:34 ET EMA Aesthetics Announces Strategic Investment in MonoTx and Secures Board Representation, Advancing Regenerative Aesthetics Innovation
understand, develop, and unlock the regenerative and therapeutic potential of each component.Media ContactsEMA Aesthetics Ltd.Tel: +971 4 383 [email protected]
More news about: EMA Aesthetics
Mar 13, 2026, 07:48 ET XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026
Financial CommunicationsTel: +86-10-6508-0677Email: [email protected] the United States:Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050Email:
More news about: XtalPi Inc.
Mar 13, 2026, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
law.Investor Contact: Acurx Pharmaceuticals, Inc.David P. LuciPresident & Chief Executive OfficerTel: 917-533-1469Email: [email protected]
More news about: Acurx Pharmaceuticals, Inc.
Mar 13, 2026, 07:00 ET Cango Inc. to Report Fourth Quarter and Full Year 2025 Financial Results
CommunicationsCango Inc.Email: [email protected] Christensen AdvisoryTel: +852 2117 0861Email: [email protected]
More news about: Cango Inc.
Mar 13, 2026, 07:00 ET OPC Energy Announces $255 Million (NIS 800 Million) Equity Raise with Leading Israeli Institutional Investors
TEL AVIV, Israel, March 13, 2026 /PRNewswire/ -- OPC Energy Ltd. (TASE: OPCE), a leading Independent Power Producer (IPP) operating in Israel and the United States that provides reliable and efficient electricity through a
More news about: OPC Energy
Mar 13, 2026, 05:30 ET RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results
CommunicationsJenny CaiTel: +86-10-6508-0677Email: [email protected] the United States:Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050Email:
More news about: RLX Technology Inc.
Mar 13, 2026, 05:00 ET PRIVACY ALERT: Figure Lending Corp Under Investigation for Data Breach of Nearly 1 Million User Records
nationwide.ContactSonum DixitSchubert Jonckheer & Kolbe [email protected]Tel: 415-299-8207
More news about: Schubert Jonckheer & Kolbe LLP
Mar 13, 2026, 03:45 ET SciBase: Interim report
contact: Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected] Advisor (CA):DNB Carnegie Investment Bank AB (publ)Tel: +46 8 588 68 570Email:
More news about: SciBase
Mar 12, 2026, 19:50 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Victoria's Secret & Co. - VSCO
trading sessions, to close at $146.73 per share on March 6, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:45 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
share, or 10.35%, to close at $107.28 per share on July 15, 2025.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:40 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST
share, or 37.04%, to close at $3.91 per share on January 9, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:39 ET BBWI Deadline: BBWI Investors Have Opportunity to Lead Bath & Body Works, Inc. Securities Fraud Lawsuit
Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Mar 12, 2026, 19:35 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Trip.com Group Limited of Class Action Lawsuit and Upcoming Deadlines - TCOM
ADR, or 17.05%, to close at $62.78 per ADR on January 14, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:30 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Driven Brands Holdings Inc. of Class Action Lawsuit and Upcoming Deadlines - DRVN
or 30.16%, to close at $11.60 per share on February 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:25 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
or 17.6%, to close at $75.50 per share on February 4, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:20 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in monday.com Ltd. of Class Action Lawsuit and Upcoming Deadlines - MNDY
or 20.79%, to close at $77.63 per share on February 9, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:15 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Camping World Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - CWH
or 16.5%, to close at $9.06 per share on February 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:10 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. - JEF
share, or 13.53%, to close at $38.29 per share on March 6, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:05 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BlackRock, Inc. - BLK
share, or 7.69%, to close at $955.45 per share on March 6, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 19:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against ODDITY Tech Ltd. and Certain Officers - ODD
or 49.21%, to close at $14.74 per share on February 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Mar 12, 2026, 18:55 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arq, Inc. - ARQ
share, or 48.75%, to close at $1.64 per share on March 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP